Drug Discovery and the Market Today Part 3: The Focus on Solubility
Dr. David Elder is the Externalization Director for GlaxoSmithKline. Here, he talks exclusively to Pharma IQ on his perspective across the industry, including CROs, regulations, and strategising for efficiency..
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.